Cargando…
Efficacy and Safety of Qinghao Biejia Decoction in the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
Objective: This meta-analysis aimed to systematically assess the therapeutic efficacy and safety of Qinghao Biejia decoction combined with conventional chemical medicine in patients with systemic lupus erythematosus (SLE), and to provide reference for clinical medication. Methods: Multiple databases...
Autores principales: | Li, Xiaobo, He, Zhouqing, Ru, Li, Yuan, Yueming, Yuan, Zheng, Chen, Pengfei, Xu, Zhiyong, Wang, Qi, Song, Jianping, Xu, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378134/ https://www.ncbi.nlm.nih.gov/pubmed/34421590 http://dx.doi.org/10.3389/fphar.2021.669269 |
Ejemplares similares
-
Qinghao-Biejia Herb Pair Alleviates Pristane-Induced Lupus-Like Disease and Associated Renal and Aortic Lesions in ApoE(−/−) Mice
por: Hong, Jiaze, et al.
Publicado: (2022) -
Acute and subacute oral toxicity assessment of Gancao Xiexin decoction in Sprague-Dawley rats
por: Ru, Li, et al.
Publicado: (2023) -
Integrating Network Pharmacology and Experimental Validation to Explore the Effects and Mechanisms of Qinghao Biejia Decoction and Its Active Compound Artemisinin B Against Non-Small-Cell Lung Cancer
por: Ye, Yonghua, et al.
Publicado: (2023) -
Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k/AKT Pathway
por: Cheng, Xin, et al.
Publicado: (2022) -
Shengma Biejia Decoction Inhibits Cell Growth in Multiple Myeloma by Inducing Autophagy-Mediated Apoptosis Through the ERK/mTOR Pathway
por: Dai, Huibo, et al.
Publicado: (2021)